
-
Swiss gold refining sector hits US tariff mine
-
Ter Stegen responds after Barcelona strips him of captaincy
-
Chelsea's Broja joins Burnley on five-year deal
-
Three centurions as 'ruthless' New Zealand pile on runs against Zimbabwe
-
Three die in Greece as gales stoke fires, disrupt ferries
-
ICC unseals Libya war crimes warrant for militia officer
-
Montreal protagonists Mboko, Osaka out of Cincinnati Open
-
Trump says court halt of tariffs would cause 'Great Depression'
-
Glasner says demotion to Conference League would punish 'innocent' Palace
-
New Zealand build big total in 2nd Test against Zimbabwe
-
Trump hosts foes Armenia, Azerbaijan in his latest peace initiative
-
Nigerian scientists await return of Egusi seeds sent to space
-
Pioneer spirit drives Swiss solar-powered plane altitude attempt
-
Thyssenkrupp to spin off marine division amid defence boom
-
Vance and Lammy talk Gaza, fish as US VP starts UK holiday
-
Israel plans to 'take control' of Gaza City, sparking wave of criticism
-
Putin taps key allies ahead of Trump summit, sanctions deadline
-
Two tourists die, fires erupt in Greece amid gale-force winds
-
Lens sign France international Thauvin from Udinese
-
Gold futures hit record on US tariff shock, stocks wobble
-
Man Utd training ground upgrade will foster 'winning culture': Ratcliffe
-
Two tourists die at sea in Greece amid gale-force winds
-
'Optimistic': Champagne growers hope for US tariff shift
-
French firefighters optimistic after controlling vast wildfire
-
Germany suspends arms exports to Israel for use in Gaza
-
Stocks waver, gold futures hit record on US tariff updates
-
Guessand says he jumped at chance to join Aston Villa after sealing move
-
Israel to 'take control' of Gaza City, sparking wave of criticism
-
Accumulating bitcoin a risky digital rush by companies?
-
Liverpool's Slot hints at fresh Isak bid despite 'attacking power'
-
PSG to sign Lille goalkeeper Lucas Chevalier: source
-
Oil industry presence surges at UN plastic talks: NGOs
-
Kipyegon says a woman will run a sub-four minute mile
-
Tokyo soars on trade deal relief as most Asian markets limp into weekend
-
Israel to 'take control' of Gaza City after approving new war plan
-
Australian A-League side Western United stripped of licence
-
'Back home': family who fled front buried after Kyiv strike
-
Indonesia cracks down on pirate protest flag
-
Israeli army will 'take control' of Gaza City: PM's office
-
Australian mushroom murderer accused of poisoning husband
-
Coventry's mettle tested by Russian Olympic debate, say former IOC figures
-
Library user borrows rare Chinese artwork, returns fakes: US officials
-
Parisians hot under the collar over A/C in apartments
-
Crypto group reportedly says it planned sex toy tosses at WNBA games
-
American Shelton tops Khachanov to win first ATP Masters title in Toronto
-
Tokyo soars on trade deal relief as Asian markets limp into weekend
-
New species teem in Cambodia's threatened karst
-
Australian mushroom murderer accused of poisoning husband: police
-
Solid gold, royal missives and Nobel noms: how to win Trump over
-
Canadian teen Mboko outlasts Osaka to win WTA Montreal crown
RYCEF | -0.7% | 14.35 | $ | |
CMSC | 0.13% | 22.99 | $ | |
GSK | 0.67% | 37.835 | $ | |
AZN | -0.37% | 73.78 | $ | |
SCS | -0.85% | 15.865 | $ | |
RBGPF | -5.79% | 71.84 | $ | |
BTI | 0.77% | 57.13 | $ | |
SCU | 0% | 12.72 | $ | |
RIO | 2.13% | 62.09 | $ | |
CMSD | -0.04% | 23.51 | $ | |
VOD | 1.01% | 11.375 | $ | |
JRI | 0.16% | 13.432 | $ | |
BCE | 2.82% | 24.47 | $ | |
RELX | -1.91% | 48.135 | $ | |
BCC | -0.74% | 82.575 | $ | |
BP | 0.32% | 34.3 | $ | |
NGG | -1.32% | 71.14 | $ |

US Justice Dept takes abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The move by the administration of President Joe Biden came just hours after an appeals court blocked moves to ban mifepristone, but limited access to the drug used for more than half of the abortions in the United States.
"We will be seeking emergency relief from the Supreme Court... to protect Americans' access to safe and effective reproductive care," US Attorney General Merrick Garland said.
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone should remain available for now, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority federal appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the Food and Drug Administration's two-decades old approval of the drug last Friday.
The appeals court ruling was denounced by Planned Parenthood, the ACLU, the Center for Reproductive Rights and other groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
- 'Win' -
The anti-abortion group Susan B. Anthony described the latest ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, imposing a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
O.Salim--SF-PST